NT5E and gastric cancer: High CD73 expression associates with favorable overall survival in gastric cancer;Meta-analysis study reports large heterogeneity for high CD73 expression for tumors (tumors: ovarian, breast, colorectal, gastric, gallbladder, prostate, rectal, renal, bladder, head and neck cancer, and NSCLC)